Faculty Opinions recommendation of Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK).
Read the full review for this Faculty Opinions recommended article: Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK).
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
cdercder
CFD
科研狗
学术文献互助
Scorpia112
小牛马阿欢
YWY
东方元语
尊嘟假嘟
碎觉觉
殷勤的紫槐
我是小汪
寮信
GingerF
OK
核桃
畔畔
挖掘机
8R60d8
皖公网安备34019202002308
